These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20620743)

  • 1. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
    Rijzewijk LJ; Jonker JT; van der Meer RW; Lubberink M; de Jong HW; Romijn JA; Bax JJ; de Roos A; Heine RJ; Twisk JW; Windhorst AD; Lammertsma AA; Smit JW; Diamant M; Lamb HJ
    J Am Coll Cardiol; 2010 Jul; 56(3):225-33. PubMed ID: 20620743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
    Rijzewijk LJ; van der Meer RW; Smit JW; Diamant M; Bax JJ; Hammer S; Romijn JA; de Roos A; Lamb HJ
    J Am Coll Cardiol; 2008 Nov; 52(22):1793-9. PubMed ID: 19022158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects.
    van der Meer RW; Hammer S; Smit JW; Frölich M; Bax JJ; Diamant M; Rijzewijk LJ; de Roos A; Romijn JA; Lamb HJ
    Diabetes; 2007 Dec; 56(12):2849-53. PubMed ID: 17717279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function.
    Hammer S; Snel M; Lamb HJ; Jazet IM; van der Meer RW; Pijl H; Meinders EA; Romijn JA; de Roos A; Smit JW
    J Am Coll Cardiol; 2008 Sep; 52(12):1006-12. PubMed ID: 18786482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women.
    Utz W; Engeli S; Haufe S; Kast P; Hermsdorf M; Wiesner S; Pofahl M; Traber J; Luft FC; Boschmann M; Schulz-Menger J; Jordan J
    Heart; 2011 Oct; 97(19):1585-9. PubMed ID: 21775510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.
    van der Meer RW; Rijzewijk LJ; de Jong HW; Lamb HJ; Lubberink M; Romijn JA; Bax JJ; de Roos A; Kamp O; Paulus WJ; Heine RJ; Lammertsma AA; Smit JW; Diamant M
    Circulation; 2009 Apr; 119(15):2069-77. PubMed ID: 19349323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal hepatic energy homeostasis in type 2 diabetes.
    Szendroedi J; Chmelik M; Schmid AI; Nowotny P; Brehm A; Krssak M; Moser E; Roden M
    Hepatology; 2009 Oct; 50(4):1079-86. PubMed ID: 19637187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic MRI of myocardial and hepatic triglyceride content in response to nutritional interventions.
    Lamb HJ; Smit JW; van der Meer RW; Hammer S; Doornbos J; de Roos A; Romijn JA
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):573-9. PubMed ID: 18685452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study.
    McGavock JM; Lingvay I; Zib I; Tillery T; Salas N; Unger R; Levine BD; Raskin P; Victor RG; Szczepaniak LS
    Circulation; 2007 Sep; 116(10):1170-5. PubMed ID: 17698735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve.
    Korosoglou G; Humpert PM; Ahrens J; Oikonomou D; Osman NF; Gitsioudis G; Buss SJ; Steen H; Schnackenburg B; Bierhaus A; Nawroth PP; Katus HA
    J Magn Reson Imaging; 2012 Apr; 35(4):804-11. PubMed ID: 22068959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
    Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function.
    van der Meer RW; Rijzewijk LJ; Diamant M; Hammer S; Schär M; Bax JJ; Smit JW; Romijn JA; de Roos A; Lamb HJ
    Eur Heart J; 2008 Jun; 29(12):1516-22. PubMed ID: 18492680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
    Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
    J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.
    Thamer C; Tschritter O; Haap M; Shirkavand F; Machann J; Fritsche A; Schick F; Häring H; Stumvoll M
    Horm Metab Res; 2005 Apr; 37(4):246-51. PubMed ID: 15952086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver.
    Perseghin G; Lattuada G; De Cobelli F; Esposito A; Belloni E; Ntali G; Ragogna F; Canu T; Scifo P; Del Maschio A; Luzi L
    Hepatology; 2008 Jan; 47(1):51-8. PubMed ID: 17955548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.
    Toledo FG; Sniderman AD; Kelley DE
    Diabetes Care; 2006 Aug; 29(8):1845-50. PubMed ID: 16873790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.